Visual Impairment at Presentation in Pediatric Uveitis: A Multicentric Study in 477 Children Across Southern and Eastern India.

IF 2.6 4区 医学 Q2 OPHTHALMOLOGY Ocular Immunology and Inflammation Pub Date : 2024-09-11 DOI:10.1080/09273948.2024.2401134
Shabtab Nasir,Mohammed Hasnat Ali,Anamika Patel,Anup Kelgaonkar,Sameera Nayak,Mudit Tyagi,Somasheila Murthy,Soumyava Basu
{"title":"Visual Impairment at Presentation in Pediatric Uveitis: A Multicentric Study in 477 Children Across Southern and Eastern India.","authors":"Shabtab Nasir,Mohammed Hasnat Ali,Anamika Patel,Anup Kelgaonkar,Sameera Nayak,Mudit Tyagi,Somasheila Murthy,Soumyava Basu","doi":"10.1080/09273948.2024.2401134","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nTo evaluate visual impairment (VI) at presentation in pediatric uveitis cases in southern and eastern India.\r\n\r\nMETHODS\r\nRetrospective analysis of 477 children across four tertiary centers (2015-2020). Best-documented visual acuity (ETDRS letters) in the better eye was used to categorize VI.\r\n\r\nRESULTS\r\nMean age at presentation was 11 ± 3.7 years; 43.8% were females, and 64.8% bilateral. Of 205 patients with complete investigations, 32.7% were undifferentiated uveitis, 31.7% infectious, 25.7% juvenile idiopathic arthritis-associated uveitis, and 10.2% other non-infectious uveitis. At presentation, 79.0% had none to mild VI, 12.6% moderate VI, and 8.4% severe VI to blindness. On generalized estimating equations analysis for individual eyes, prior oral steroids and older age were risk factors, while female gender, prior topical corticosteroids and immunosuppressive therapy were protective against moderate and/or severe VI.\r\n\r\nCONCLUSIONS\r\nOver a fifth of pediatric uveitis cases present with moderate/severe VI, especially in older age or with prior oral corticosteroid therapy.","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2024.2401134","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

OBJECTIVE To evaluate visual impairment (VI) at presentation in pediatric uveitis cases in southern and eastern India. METHODS Retrospective analysis of 477 children across four tertiary centers (2015-2020). Best-documented visual acuity (ETDRS letters) in the better eye was used to categorize VI. RESULTS Mean age at presentation was 11 ± 3.7 years; 43.8% were females, and 64.8% bilateral. Of 205 patients with complete investigations, 32.7% were undifferentiated uveitis, 31.7% infectious, 25.7% juvenile idiopathic arthritis-associated uveitis, and 10.2% other non-infectious uveitis. At presentation, 79.0% had none to mild VI, 12.6% moderate VI, and 8.4% severe VI to blindness. On generalized estimating equations analysis for individual eyes, prior oral steroids and older age were risk factors, while female gender, prior topical corticosteroids and immunosuppressive therapy were protective against moderate and/or severe VI. CONCLUSIONS Over a fifth of pediatric uveitis cases present with moderate/severe VI, especially in older age or with prior oral corticosteroid therapy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
小儿葡萄膜炎发病时的视觉障碍:印度南部和东部 477 名儿童的多中心研究。
目的评估印度南部和东部地区小儿葡萄膜炎病例发病时的视力损伤(VI)。方法回顾性分析四个三级中心(2015-2020年)的477名儿童。结果发病时平均年龄为(11 ± 3.7)岁;43.8%为女性,64.8%为双侧。在205名接受完整检查的患者中,32.7%为未分化葡萄膜炎,31.7%为感染性葡萄膜炎,25.7%为幼年特发性关节炎相关性葡萄膜炎,10.2%为其他非感染性葡萄膜炎。就诊时,79.0%的患者无至轻度葡萄膜炎,12.6%为中度葡萄膜炎,8.4%为重度葡萄膜炎至失明。结论超过五分之一的小儿葡萄膜炎病例伴有中度/重度葡萄膜炎,尤其是年龄较大或曾接受过口服皮质类固醇治疗的病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
15.20%
发文量
285
审稿时长
6-12 weeks
期刊介绍: Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.
期刊最新文献
Acinetobacter baumannii Endogenous Endophthalmitis Presenting with Iris Nodules. Autoimmune Retinopathy Following COVID-19: A Case Report. Helicobacter pylori and Its Treatment Impact on Immune-Mediated Ocular Diseases. Epidemiology of Intermediate Uveitis. Limited Utility of Keratic Precipitate Morphology as an Indicator of Underlying Diagnosis in Ocular Inflammation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1